Hiie Soeorg
Tartu, Estonia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Pharmacokinetic-pharmacodynamic modeling using combined time-kill data for meropenem and colistin or polymyxin B combination effects in Acinetobacter baumannii.
Journal: Antimicrobial agents and chemotherapy
Published: June 10, 2026
LSTA1-GBM-2A: study protocol for an exploratory phase 2a randomised controlled trial evaluating tumour-homing peptide certepetide with temozolomide in glioblastoma multiforme.
Journal: BMJ open
Published: November 17, 2025
Subgroup-based model selection to improve the prediction of vancomycin concentrations.
Journal: Antimicrobial agents and chemotherapy
Published: July 23, 2025
The effect of policy measures, school holidays and travel on the incidence of SARS-CoV-2 infection in children and adults in Estonia from 2021 to 2022.
Journal: PloS one
Published: March 10, 2025
Transmitted HIV-1 drug resistance in Estonian residents and Ukrainian refugees in 2020 and 2022.
Journal: Journal of global antimicrobial resistance
Published: October 18, 2024
Population pharmacokinetic modeling of ceftriaxone in cerebrospinal fluid in children: should we be using once- or twice-daily dosing for meningitis?
Journal: Antimicrobial agents and chemotherapy
Published: October 08, 2024
Dynamics of SARS-CoV-2 lineages in children and adults in 2021 and 2022.
Journal: PloS one
Published: July 15, 2024
Prospective validation of a model-informed precision dosing tool for vancomycin treatment in neonates.
Journal: Antimicrobial agents and chemotherapy
Published: April 05, 2024
Subgroup identification-based model selection to improve the predictive performance of individualized dosing.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: July 17, 2023
Prediction of C-reactive protein dynamics during meropenem treatment in neonates and infants.
Journal: British journal of clinical pharmacology
Published: July 05, 2023
Pharmacokinetics of oral spironolactone in infants up to 2 years of age.
Journal: European journal of clinical pharmacology
Published: June 22, 2023
Last Updated: 09/26/2026